Search
for
Sort by
Research 241–270 of 287
- Macrophage ferroportin is essential for stromal cell proliferation in wound healing
- Malnutrition and Allergies: Tipping the Immune Balance towards Health
- Iron Deficiency in Menstruating Adult Women: Much More than Anemia
- Micronutrients in hair loss
- Abstracts from the 55th European Society of Human Genetics (ESHG) Conference: e-Posters
- Iron Deficiency-Induced Hair Loss Is Associated with ROS-Mediated Disruption of Wnt/β-Catenin Signaling
- 26-SNP Panel Aids Guiding Androgenetic Alopecia Therapy and Provides Insight into Mechanisms of Action
- Finasteride Induces Epigenetic Alteration of TMPRss2 Gene Expression: A Potential role in Severe Acute Respiratory Syndrome-Corona Virus-2 Inhibition
- Spiking dependence of SARS‐CoV‐2 pathogenicity on TMPRSS2
- The role of androgens in COVID-19
- Repurposing existing drugs for COVID-19: an endocrinology perspective
- Skin amidst COVID ‐19 pandemic
- Use of Antiandrogens as Therapeutic Agents in COVID-19 Patients
- Human genetic basis of coronavirus disease 2019
- Candidate genes of SARS-CoV-2 gender susceptibility
- Host Genetic Susceptibility and Impacts of Dietary Factors on Covid-19
- The impact of certain genetic variants (single nucleotide polymorphisms) on incidence and severity of COVID‐19
- Evaluation of SARS-CoV-2 Entry, Inflammation and New Therapeutics in Human Lung Tissue Cells
- Evaluation of SARS-CoV-2 entry, inflammation and new therapeutics in human lung tissue cells
- Prevalence of telogen effluvium hair loss in COVID-19 patients and its relationship with disease severity
- Iron deficiency and diffuse nonscarring scalp alopecia in women: More pieces to the puzzle
- Transdermal Composite Microneedle Composed of Mesoporous Iron Oxide Nanoraspberry and PVA for Androgenetic Alopecia Treatment
- Obstructive sleep apnea, low transferrin saturation levels, and male‐pattern baldness
- Untangling the hairy issue of iron deficiency: Making progress
- 5-Alpha-Reductase Inhibitors Reduce Remission Time of COVID-19: Results From a Randomized Double Blind Placebo Controlled Interventional Trial in 130 SARS-CoV-2 Positive Men
- Proxalutamide (GT0918) Reduces the Rate of Hospitalization in mild-to-moderate COVID-19 Female Patients: A Randomized Double-Blinded Placebo-Controlled Two-Arm Parallel Trial
- Proxalutamide Improves Inflammatory, Immunologic, and Thrombogenic Markers in Mild-to-Moderate COVID-19 Males and Females: an Exploratory Analysis of a Randomized, Double-Blinded, Placebo-Controlled Trial Early Antiandrogen Therapy (EAT) with Proxalutamide (The EAT-Proxa Biochemical AndroCoV-Trial)
- Male reproductive health after 3 months from SARS-CoV-2 infection: a multicentric study
- O papel dos andrógenos na alopecia androgenética associada à gravidade do COVID-19
- Growth retardation and hair loss in transgenic mice overexpressing human H-ferritin gene